257 related articles for article (PubMed ID: 7533857)
1. Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.
Baier G; Baier-Bitterlich G; Looney DJ; Altman A
J Virol; 1995 Apr; 69(4):2357-65. PubMed ID: 7533857
[TBL] [Abstract][Full Text] [Related]
2. High affinity mouse-human chimeric Fab against hepatitis B surface antigen.
Bose B; Khanna N; Acharya SK; Sinha S
World J Gastroenterol; 2005 Dec; 11(48):7569-78. PubMed ID: 16437680
[TBL] [Abstract][Full Text] [Related]
3. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
4. Troybodies and pepbodies.
Lunde E; Lauvrak V; Rasmussen IB; Schjetne KW; Thompson KM; Michaelsen TE; Brekke OH; Sollid LM; Bogen B; Sandlie I
Biochem Soc Trans; 2002 Aug; 30(4):500-6. PubMed ID: 12196123
[TBL] [Abstract][Full Text] [Related]
5. Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.
Denkberg G; Cohen CJ; Lev A; Chames P; Hoogenboom HR; Reiter Y
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9421-6. PubMed ID: 12093904
[TBL] [Abstract][Full Text] [Related]
6. Recognition of HLA-DR1/DRB1*0101 molecules presenting HLA-A2 derived peptides by a human recombinant antibody, Fab-5 A1.
Löffler D; Welschof M; Goldmann SF; Wölpl A
Eur J Immunogenet; 1998 Oct; 25(5):339-47. PubMed ID: 9805656
[TBL] [Abstract][Full Text] [Related]
7. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus.
Liang M; Chu YK; Schmaljohn C
Virology; 1996 Mar; 217(1):262-71. PubMed ID: 8599211
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of class II major histocompatibility complex molecules on antigen-presenting cells by antibody fragments.
Vidović D; Falcioni F; Siklodi B; Belunis CJ; Bolin DR; Ito K; Nagy ZA
Eur J Immunol; 1995 Dec; 25(12):3349-55. PubMed ID: 8566022
[TBL] [Abstract][Full Text] [Related]
10. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
[TBL] [Abstract][Full Text] [Related]
11. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
12. Recognition by class II alloreactive T cells of processed determinants from human serum proteins.
Panina-Bordignon P; Corradin G; Roosnek E; Sette A; Lanzavecchia A
Science; 1991 Jun; 252(5012):1548-50. PubMed ID: 1710827
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
[TBL] [Abstract][Full Text] [Related]
14. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
[TBL] [Abstract][Full Text] [Related]
15. Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virus.
Samuelsson A; Chiodi F; Ohman P; Putkonen P; Norrby E; Persson MA
Virology; 1995 Mar; 207(2):495-502. PubMed ID: 7886953
[TBL] [Abstract][Full Text] [Related]
16. TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes.
Dahan R; Tabul M; Chou YK; Meza-Romero R; Andrew S; Ferro AJ; Burrows GG; Offner H; Vandenbark AA; Reiter Y
Eur J Immunol; 2011 May; 41(5):1465-79. PubMed ID: 21469129
[TBL] [Abstract][Full Text] [Related]
17. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
18. The chimeric mouse-human anti-CD4 Fab 13B8.2 expressed in baculovirus inhibits both antigen presentation and HIV-1 promoter activation.
Bès C; Cerutti M; Briant-Longuet L; Bresson D; Peraldi-Roux S; Pugnière M; Mani JC; Pau B; Devaux C; Granier C; Devauchelle G; Chardès T
Hum Antibodies; 2001; 10(2):67-76. PubMed ID: 11673661
[TBL] [Abstract][Full Text] [Related]
19. Two-phase approach for the expression of high-affinity human anti-human immunodeficiency virus immunoglobulin Fab domains in Escherichia coli.
Takeda S; Dorfman NA; Robert-Guroff M; Notkins AL; Rando RF
Hybridoma; 1995 Feb; 14(1):9-18. PubMed ID: 7768538
[TBL] [Abstract][Full Text] [Related]
20. Targeting antigens to an invariant epitope of the MHC Class II DR molecule potentiates the immune response to subunit vaccines.
Gil F; Pérez-Filgueira M; Barderas MG; Pastor-Vargas C; Alonso C; Vivanco F; Escribano JM
Virus Res; 2011 Jan; 155(1):55-60. PubMed ID: 20817054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
